Q: You began studying breast cancer early in your career. How did you become interested in this line of inquiry and what made you think breast cancer could be inherited? DR. KING: When I started working in cancer biology in 1974, I got interested in...
In: News, Press Release
New Haven, CT August 13, 2001-- Molecular Staging Inc., today announced that, together with Amersham Pharmacia Bio-tech, the two companies have developed a simple method of using Rolling Circle Amplification to copy circular DNA for sequencing, 10,000...
In: Press Release
New Haven, CT. June 4, 2001 - Molecular Staging Inc. (MSI) today confirmed that Motorola will not exercise an option to license Rolling Circle Amplification technology (RCAT™) for applications in the clinical diagnostics market. Instead, Motorola Inc....
Funding will enhance Molecular Staging’s leadership position in signal and target amplification and accelerate MSI’s efforts in the proteomics, genomics and molecular diagnostics markets. NEW HAVEN, CT -- Molecular Staging Inc. (MSI), a...
In: Press Release
Ultra-sensitive Prototype Assay for Prostate Cancer Marker Also Reported PRINCETON, N.J., Oct. 2 /PRNewswire/ -- AxCell Biosciences Corporation, a subsidiary of Cytogen Corporation (Nasdaq: CYTO - news) and Molecular Staging, Inc., (MSI), Guilford, CT,...
Latest comments